Torrent Pharma, the flagship Company of Torrent Group, with a turnover of Rs. 6080 Cr is one of the leading Pharma companies in the Country. We are the pioneers in initiating the concept of niche marketing in India and today we rank amongst the leaders in the therapeutic segments of Cardiovascular (CV) and Central Nervous System (CNS).We also have significant presence in Gastro-Intestinal, Diabetology, Anti-Infective and Pain Management segments. Torrent Pharma has crossed many geographical boundaries with presence in more than 40 countries. The Company is ranked first amongst Indian Companies for having largest market share in Brazil and Germany.

Ahmedabad-headquartered drug major Torrent Pharma has managed to turn around its business in Brazil, where it is the largest Indian generics player, with revenue growing by 25 per cent in April-December to Rs 484 crore. During the third quarter, the company's Brazil business posted revenue growth of 35 per cent, year on year, to Rs 159 crore. In 2015-16, Torrent’s revenue in Brazil declined 17 per cent to Rs 506 crore. Nastoljnaya igra in love kartochki.

Products associated with Torrent Pharmaceuticals Ltd. ACISTAL 20MG TABLET AROFF 100 MG TABLET Abatitor 250mg Tablet Abatitor 250mg Tablet. Torrent Pharma has crossed many geographical boundaries with presence in more than 40 countries. The Company is ranked first amongst Indian Companies for having largest market share in Brazil and Germany. Therapeutic Areas Torrent Pharma, the flagship company of the Torrent Group, is one of the leading Pharma companies in India.

A company spokesperson said the devaluation of the Brazilian real had overshadowed market growth. In 2015-16, revenue declined 17 per cent in dollar terms but grew. • Requires you to share personal information like date of birth, income, location amongst other fields. This information alongwith your contact information will be shared with the partners associated with this program, who contribute towards subsidizing the offer. By subscribing to this product you acknowledge and accept that our Partners may choose to contact you with offers of their products and services. • This is an optional offer - Not comfortable with sharing personal data - please opt for the full price offer which requires you to share minimal information NOTE. • This product is a monthly auto renewal product.

• If you have been a past Free/Registered User of The Wall Street Journal online - You will not be eligible for the seamless account creation on The Wall Street Journal online facility. Kindly your non-confidential password on The Wall Street Journal online to enable us activate your access from the backend. • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal.

We do not offer any refunds. • To cancel, communicate from your registered email id and send the mail with the request to. Include your contact number for easy reference. Requests mailed to any other ID will not be acknowledged or actioned upon. • Saving calculated at the current WSJ price - US $ 1 for the first 3 months and US $ 28.99 thereafter Conversion scale 1 US$ = 65.04 INR • If you have been a past Free/Registered User of The Wall Street Journal online - You will not be eligible for the seamless account creation on The Wall Street Journal online facility. Kindly your non-confidential password on The Wall Street Journal online to enable us activate your access from the backend. • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal.